Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Anemia × ferric gluconate × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Iron Deficiencies 1 Anemia 1

Interventions

Epoetin Alfa 7 ferric carboxymaltose 6 epoetin beta 6 Darbepoetin alfa 3 ferrous sulfate 2 ferrous fumarate 2 Radiotherapy 2 iron isomaltoside 1000 1 ferrous succinate 1 ferric gluconate 1 Vitamin B 12 1 Thiotepa 1 Standard of Care 1 Hematinics 1 Folic Acid 1 Filgrastim 1 Erythropoietin 1 Cyclophosphamide 1 Cisplatin 1 Cholecalciferol 1 Brachytherapy 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00224068 2012-03-02

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Watson Pharmaceuticals

Phase 4 Completed

Classical hematology

Iron Deficiencies, Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡